272 related articles for article (PubMed ID: 27169391)
1. Hypofractionated stereotactic radiotherapy for brain metastases from lung cancer : Evaluation of indications and predictors of local control.
Ishihara T; Yamada K; Harada A; Isogai K; Tonosaki Y; Demizu Y; Miyawaki D; Yoshida K; Ejima Y; Sasaki R
Strahlenther Onkol; 2016 Jun; 192(6):386-93. PubMed ID: 27169391
[TBL] [Abstract][Full Text] [Related]
2. Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED
Kumar AMS; Miller J; Hoffer SA; Mansur DB; Coffey M; Lo SS; Sloan AE; Machtay M
J Neurooncol; 2018 Sep; 139(2):449-454. PubMed ID: 29749569
[TBL] [Abstract][Full Text] [Related]
3. Image-Guided, Linac-Based, Surgical Cavity-Hypofractionated Stereotactic Radiotherapy in 5 Daily Fractions for Brain Metastases.
Soliman H; Myrehaug S; Tseng CL; Ruschin M; Hashmi A; Mainprize T; Spears J; Das S; Yang V; da Costa L; Maralani P; Heyn C; Atenafu EG; Sahgal A
Neurosurgery; 2019 Nov; 85(5):E860-E869. PubMed ID: 31173150
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated stereotactic radiotherapy for the treatment of brain metastases.
Kwon AK; Dibiase SJ; Wang B; Hughes SL; Milcarek B; Zhu Y
Cancer; 2009 Feb; 115(4):890-8. PubMed ID: 19132728
[TBL] [Abstract][Full Text] [Related]
6. HFSRT of the resection cavity in patients with brain metastases.
Specht HM; Kessel KA; Oechsner M; Meyer B; Zimmer C; Combs SE
Strahlenther Onkol; 2016 Jun; 192(6):368-76. PubMed ID: 26964777
[TBL] [Abstract][Full Text] [Related]
7. Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection.
Navarria P; Pessina F; Cozzi L; Ascolese AM; De Rose F; Fogliata A; Franzese C; Franceschini D; Tozzi A; D'Agostino G; Comito T; Iftode C; Maggi G; Reggiori G; Bello L; Scorsetti M
Radiat Oncol; 2016 Jun; 11():76. PubMed ID: 27249940
[TBL] [Abstract][Full Text] [Related]
8. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated Stereotactic Radiosurgery and Radiotherapy to Large Resection Cavity of Metastatic Brain Tumors.
Lima LC; Sharim J; Levin-Epstein R; Tenn S; Teles AR; Kaprealian T; Pouratian N
World Neurosurg; 2017 Jan; 97():571-579. PubMed ID: 27777153
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases.
Manning MA; Cardinale RM; Benedict SH; Kavanagh BD; Zwicker RD; Amir C; Broaddus WC
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):603-8. PubMed ID: 10837942
[TBL] [Abstract][Full Text] [Related]
11. Outcomes Following Hypofractionated Stereotactic Radiotherapy in the Management of Brain Metastases.
Ahmed KA; Sarangkasiri S; Chinnaiyan P; Sahebjam S; Yu HH; Etame AB; Rao NG
Am J Clin Oncol; 2016 Aug; 39(4):379-83. PubMed ID: 24755663
[TBL] [Abstract][Full Text] [Related]
12. Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation.
Pessina F; Navarria P; Cozzi L; Tomatis S; Ascolese AM; Franzese C; Toschi L; Santoro A; De Rose F; Franceschini D; Bello L; Scorsetti M
Br J Radiol; 2017 Apr; 90(1072):20170022. PubMed ID: 28256924
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.
Fiorentino A; Giaj-Levra N; Tebano U; Mazzola R; Ricchetti F; Fersino S; Di Paola G; Aiello D; Ruggieri R; Alongi F
Radiol Med; 2017 Sep; 122(9):676-682. PubMed ID: 28447313
[TBL] [Abstract][Full Text] [Related]
14. CyberKnife Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy As First-line Treatments for Imaging-diagnosed Intracranial Meningiomas.
Manabe Y; Murai T; Ogino H; Tamura T; Iwabuchi M; Mori Y; Iwata H; Suzuki H; Shibamoto Y
Neurol Med Chir (Tokyo); 2017 Dec; 57(12):627-633. PubMed ID: 29021413
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapeutic management of vestibular schwannomas using size- and location-adapted fractionation regimens to maximize the therapeutic ratio.
Slane BG; Goyal U; Grow JL; Morrison C; Hullett CR; Gordon J; Sanan A; Stea B
Pract Radiat Oncol; 2017; 7(3):e233-e241. PubMed ID: 28089525
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters.
Jiang XS; Xiao JP; Zhang Y; Xu YJ; Li XP; Chen XJ; Huang XD; Yi JL; Gao L; Li YX
Radiat Oncol; 2012 Mar; 7():36. PubMed ID: 22429918
[TBL] [Abstract][Full Text] [Related]
17. Evidence of dose-response following hypofractionated stereotactic radiotherapy to the cavity after surgery for brain metastases.
Garimall S; Shanker M; Johns E; Watkins T; Olson S; Huo M; Foote MC; Pinkham MB
J Neurooncol; 2020 Jan; 146(2):357-362. PubMed ID: 31907796
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic irradiation for intracranial arteriovenous malformation using stereotactic radiosurgery or hypofractionated stereotactic radiotherapy.
Chang TC; Shirato H; Aoyama H; Ushikoshi S; Kato N; Kuroda S; Ishikawa T; Houkin K; Iwasaki Y; Miyasaka K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):861-70. PubMed ID: 15465204
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated stereotactic radiotherapy using CyberKnife as a boost treatment for head and neck cancer, a multi-institutional survey: impact of planning target volume.
Yamazaki H; Ogita M; Himei K; Nakamura S; Yoshida K; Kotsuma T; Yamada Y; Fujiwara M; Baek S; Yoshioka Y
Anticancer Res; 2014 Oct; 34(10):5755-9. PubMed ID: 25275085
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy after resection of brain metastases. Frameless image-guided LINAC-based radiosurgery and stereotactic hypofractionated radiotherapy.
Broemme J; Abu-Isa J; Kottke R; Beck J; Wiest R; Malthaner M; Schmidhalter D; Raabe A; Aebersold DM; Pica A
Strahlenther Onkol; 2013 Sep; 189(9):765-70. PubMed ID: 23934329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
